Today: 7 February 2026
Subscribe
Browse Category

Cryptocurrency News 15 January 2026 - 16 January 2026

IREN stock price jumps nearly 9% as crypto miners rally on AI data-center pivot

IREN stock price jumps nearly 9% as crypto miners rally on AI data-center pivot

IREN shares rose 8.6% to $56.35 Friday morning as crypto mining stocks outperformed despite bitcoin slipping 1.7% to $94,897. Riot Platforms announced a 10-year, $311 million data center deal with AMD. IREN’s upcoming earnings report is expected after markets close on Feb. 18. Investors are watching AI infrastructure moves and recent upgrades from analysts.
16 January 2026
······
XRP price slips as Coinbase opposition stalls key U.S. crypto bill — what traders watch next

XRP price slips as Coinbase opposition stalls key U.S. crypto bill — what traders watch next

XRP fell about 2% to $2.06 after the U.S. Senate Banking Committee postponed a key crypto regulation bill, following criticism from Coinbase CEO Brian Armstrong. Bitcoin and ether also slipped, tracking broader market weakness. Ripple announced preliminary approval for a payments license in Luxembourg. The Senate Agriculture Committee plans to release new legislative text by Jan. 21.
16 January 2026
··
XRP price slips toward $2 as U.S. crypto bill markup is postponed — what traders watch next

XRP price slips toward $2 as U.S. crypto bill markup is postponed — what traders watch next

XRP fell about 2.6% to $2.06 in early Friday trading, tracking declines in major cryptocurrencies. The U.S. Senate Banking Committee postponed a key markup on crypto market structure legislation, citing ongoing talks. Ripple secured preliminary approval for an EMI license in Luxembourg, expanding its regulatory foothold in Europe. Trading volume for XRP reached $2.5 billion, per CoinMarketCap.
16 January 2026
·
Circle stock dives nearly 10% as Senate crypto bill hits snag — what CRCL traders watch next

Circle stock dives nearly 10% as Senate crypto bill hits snag — what CRCL traders watch next

Circle Internet Group shares fell 9.7% to $76.60 after the Senate Banking Committee postponed a crypto bill markup, following Coinbase CEO Brian Armstrong’s withdrawal of support. The stock traded between $84.74 and $76.22. Coinbase dropped 6.5%, Robinhood lost 7.8%, and bitcoin slipped 0.9%. Lawmakers face a January 21 deadline for new bill text and a January 27 markup.
16 January 2026
····
BitMine (BMNR) stock drops after-hours after $200 million MrBeast investment disclosure

BitMine (BMNR) stock drops after-hours after $200 million MrBeast investment disclosure

BitMine Immersion Technologies shares dropped 5.7% to $30.87 in after-hours trading Thursday after announcing a planned $200 million equity investment in Beast Industries, founded by YouTuber MrBeast. The company urged shareholders to approve an increase in authorized shares, warning it may soon run out. BitMine did not specify how it would fund the deal. About 46.8 million shares traded hands.
16 January 2026
··
XRP price slips today as Senate delays crypto bill, Ripple rolls out $150 million LMAX deal

XRP price slips today as Senate delays crypto bill, Ripple rolls out $150 million LMAX deal

XRP fell 3.3% to $2.07 in late Thursday trading after the Senate Banking Committee postponed a session on a key crypto bill. Bitcoin and ether also declined. Ripple announced a $150 million partnership with LMAX Group and received preliminary approval for an EU payments license, but neither move steadied XRP. Senate Agriculture Committee plans to release its own crypto bill text by Jan. 21.
15 January 2026
·
Bitcoin price slides near $95,500 as Senate crypto bill stalls; Coinbase, Strategy shares drop

Bitcoin price slides near $95,500 as Senate crypto bill stalls; Coinbase, Strategy shares drop

Bitcoin fell 2% to $95,528 in late trading, pulling Coinbase down 6.5%, Strategy 4.7%, and Marathon Digital 3.9%. The Senate Banking Committee abruptly delayed a key session on crypto market rules after Coinbase’s CEO opposed the bill. The iShares Bitcoin Trust ETF slipped 2.6%. U.S. spot bitcoin ETFs saw $711 million in net inflows on Jan. 14 and $484 million on Jan. 13.
15 January 2026
····
Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next

Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next

Strategy Inc. (MSTR) fell 4.7% to $170.91 Thursday as bitcoin slid 2% late in the session and crypto stocks dropped. The U.S. Senate Banking Committee postponed debate on a crypto market-structure bill after Coinbase’s CEO criticized the draft. Coinbase shares dropped 6.5%, Robinhood 7.8%. Strategy will report fourth-quarter results after markets close Feb. 5.
15 January 2026
···
Circle stock (CRCL) slides as Senate stalls crypto bill, putting stablecoin rewards back in focus

Circle stock (CRCL) slides as Senate stalls crypto bill, putting stablecoin rewards back in focus

Circle shares fell 4.5% to $80.97 Thursday after a U.S. Senate panel delayed action on a crypto market-structure bill opposed by Coinbase. CEO Brian Armstrong warned the draft could end stablecoin rewards for customers. Crypto stocks broadly declined, with Coinbase down 3.2%. Investors are watching for signals ahead of the Federal Reserve’s January meeting.
15 January 2026
····
Coinbase stock slides as Senate delays crypto bill, putting bitcoin-linked shares back on edge

Coinbase stock slides as Senate delays crypto bill, putting bitcoin-linked shares back on edge

Coinbase shares fell 3.3% Thursday after the Senate Banking Committee delayed a crypto market-structure bill markup. Bitcoin slipped 0.6% to $96,418, pulling down related stocks. The delay followed Coinbase’s withdrawal of support for the draft, with CEO Brian Armstrong citing concerns over stablecoin rewards and regulatory limits. Traders are watching for signs of a rescheduled committee vote.
15 January 2026
···
High Roller Technologies stock jumps again as ROLR adds Lines.com marketing plan to Crypto.com prediction push

High Roller Technologies stock jumps again as ROLR adds Lines.com marketing plan to Crypto.com prediction push

Shares of High Roller Technologies soared 44% to $27.20 in Thursday afternoon trading, extending a two-day rally sparked by a partnership with Crypto.com for U.S. prediction markets. The stock surged 436% Wednesday after the deal was announced. High Roller also disclosed a separate letter of intent with sports media firm Lines.com. Investors await details on the planned Q1 2026 U.S. launch.
15 January 2026
···
Coinbase stock slides as Senate pauses crypto bill after Armstrong balks — what COIN investors watch next

Coinbase stock slides as Senate pauses crypto bill after Armstrong balks — what COIN investors watch next

Coinbase shares fell about 4% Thursday after the Senate Banking Committee postponed a key crypto market-structure bill. CEO Brian Armstrong said Coinbase cannot support the draft, citing concerns over tokenized equities and stablecoin rewards. Robinhood stock dropped nearly 3%. The Senate Agriculture Committee plans a separate markup on January 27.
15 January 2026
···
Visa stock edges up after UK court backs fee-cap plan, with stablecoin settlement in focus

Visa stock edges up after UK court backs fee-cap plan, with stablecoin settlement in focus

Visa shares rose 0.4% to $330.33 after a UK High Court ruling cleared the way for Britain’s payments regulator to cap cross-border card fees. Investors weighed the impact on Visa’s revenue as UK regulators consider limits that could cost merchants up to £200 million a year. Visa executives highlighted stablecoin settlement pilots and a new partnership with BVNK. The company’s annual meeting is later this month.
15 January 2026
···
MARA stock slides as Senate delays crypto bill and bitcoin eases

MARA stock slides as Senate delays crypto bill and bitcoin eases

MARA Holdings shares fell 2.6% to $10.82 Thursday as bitcoin and crypto-linked stocks slid in U.S. trading. The Senate Banking Committee delayed its markup of a key crypto market-structure bill, adding to uncertainty. Coinbase CEO Brian Armstrong criticized the draft, warning it could restrict tokenized equities and stablecoin rewards. The Senate Agriculture Committee is set to review the bill Jan. 27.
15 January 2026
······
XRP price stock: Token slips near $2.12 as Senate pauses crypto bill, Ripple cites Luxembourg nod

XRP price stock: Token slips near $2.12 as Senate pauses crypto bill, Ripple cites Luxembourg nod

XRP fell about 3% to $2.12 Thursday after the Senate Banking Committee postponed debate on a crypto regulation bill opposed by Coinbase. Ripple announced it secured preliminary approval for an EMI licence from Luxembourg’s CSSF. Bitcoin hovered near $95,500, while ether traded around $3,329. The Senate session to review H.R.3633 remains unscheduled.
15 January 2026
··
1 … 15 16 17 18 19 … 83

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop